Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Bought AMLN and wrote Nov strike 12.50 calls.

|Includes: Bristol-Myers Squibb Company (BMY)

Purchased shares at 13.50 and wrote calls at 1.72/contract.  Shares have stabalized and found a nice support after testing 11.85 last month.  The upcoming FDA ruling in 2 months on Byetta diabetes medication should be very interesting.

Disclaimer:  MD Capital Management owns AMLN